Business

Approximately 30,000 new cases of multiple myeloma are diagnosed annually in the United States, and 12,650 deaths annually are attributed to multiple myeloma.
Improved Clinical Outcomes with Newer Multiple Myeloma Therapies Associated with Increased Resource Utilization and Financial Burden
Type 2 diabetes mellitus (T2DM) affects approximately 30.3 million individuals in the United States, a number that is expected to grow to almost 36 million by the year 2030.
Impact of Step Therapy Restrictions in Diabetes Care
Neuroendocrine tumors (NETs) are rare tumors that consist of a heterogeneous group of malignancies that arise from neuroendocrine cells throughout the body.
Ovarian cancer is the eighth most common cancer among women, but ranks fifth in cancer-related causes of death, the majority of which are detected in late stages, after the cancer has metastasized.
Economic Impact of Using Tests to Guide the Treatment of Patients with Ovarian Cancer
Cancer is costly. As new cancer therapies become available that extend survival, and as the US population ages and continues to grow, the cost of cancer care is estimated to reach almost $158 billion in 2020, according to the National Cancer Institute.
More Data Analysis Is Needed to Improve Outcomes, Lower Costs, and Maximize Appropriate Resource Use
The results of several studies have demonstrated that women and men with a cancer diagnosis benefit from interventions to reduce distress and improve quality of life (QOL). However, little is known about the costs and effectiveness of such interventions.
Creative Therapeutic Activities and Support Groups Benefit All Those Involved in Cancer Care
Healthcare is becoming more complex across all disciplines, at all levels, and throughout the world. As a result, practicing medicine that emphasizes the value received from an intervention is increasingly essential to the long-term sustainability of the healthcare delivery model.
The Crucial Role of Nutrition Support Services for Hospitalized Patients
The value of drugs, whether individually or comparatively, and the definition of value itself, have emerged as acute concerns in oncology, where the cost of cancer care has evoked issues of financial toxicity. In the United States alone, the costs associated with cancer treatment have been forecast to increase 27% from their 2010 levels, to approximately $157.8 billion by 2020.
Payers’ Utilization of Value Frameworks Tools in Their Drug Coverage Decision-Making
Hyperkalemia, which is defined as an elevated serum potassium level (ie, >5.0 mEq/L), may be caused by a reduction in the renal excretion of potassium or an intracellular-to-extracellular shift in potassium that results from various acute clinical conditions. Although the kidney can adjust to a reduced number of nephrons and maintain normokalemia under steady-state conditions, it lacks the ability to respond to acute increases in potassium load and to adequately excrete potassium in patients with chronic kidney disease (CKD); the result in both cases is hyperkalemia.
Hyperkalemia in Chronic Diseases: A Serious Medical Condition in Need of Clinical Guidelines and New Treatment Options
Page 1 of 12
Results 1 - 10 of 111
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME